Dissemin is shutting down on January 1st, 2025

Published in

Nature Research, Nature Communications, 1(13), 2022

DOI: 10.1038/s41467-022-29174-y

Links

Tools

Export citation

Search in Google Scholar

Autophagy impairment in liver CD11c+ cells promotes non-alcoholic fatty liver disease through production of IL-23

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractThere has been a global increase in rates of obesity with a parallel epidemic of non-alcoholic fatty liver disease (NAFLD). Autophagy is an essential mechanism involved in the degradation of cellular material and has an important function in the maintenance of liver homeostasis. Here, we explore the effect of Autophagy-related 5 (Atg5) deficiency in liver CD11c+cells in mice fed HFD. When compared to control mice, Atg5-deficient CD11c+mice exhibit increased glucose intolerance and decreased insulin sensitivity when fed HFD. This phenotype is associated with the development of NAFLD. We observe that IL-23 secretion is induced in hepatic CD11c+myeloid cells following HFD feeding. We demonstrate that both therapeutic and preventative IL-23 blockade alleviates glucose intolerance, insulin resistance and protects against NAFLD development. This study provides insights into the function of autophagy and IL-23 production by hepatic CD11c+cells in NAFLD pathogenesis and suggests potential therapeutic targets.